Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024)
Oruka Therapeutics' (ORKA) quarterly Interest & Investment Income came in at $444000.0 in Q2 2024, down 9.94% year-on-year from $493000.0 in Q3 2023, and down 6.13% quarter-over-quarter from $473000.0 in Q1 2024.
Oruka Therapeutics (ORKA) Interest & Investment Income (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Interest & Investment Income history runs 15 years deep, the most recent figure standing at $444000.0 for Q2 2024.
- On a quarterly basis, Interest & Investment Income fell 9.94% year-over-year to $444000.0 in Q2 2024; TTM through Jun 2024 was $1.9 million, a 25.47% increase from a year earlier, with the FY2023 full-year figure at $2.0 million, up 189.93% from the prior year.
- Interest & Investment Income eased to $444000.0 in Q2 2024 per ORKA's latest filing, from $473000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $513000.0 in Q3 2023 and bottomed at $1000.0 in Q3 2020.
- The 5-year median for Interest & Investment Income is $48000.0 (2020), against an average of $199444.4.
- Across the five-year window, Interest & Investment Income tumbled 98.0% in 2020 and soared 9250.0% in 2022, its largest moves.
- Year by year, Interest & Investment Income stood at $1000.0 in 2020, then surged by 300.0% to $4000.0 in 2021, then surged by 9250.0% to $374000.0 in 2022, then surged by 33.96% to $501000.0 in 2023, then slipped by 11.38% to $444000.0 in 2024.
- Per Business Quant, the three latest ORKA Interest & Investment Income figures stand at $444000.0 (Q2 2024), $473000.0 (Q1 2024), and $501000.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Oruka Therapeutics | 949.58 Mn | 118.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 444,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 513,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 374,000.00 |
| Sep 30, 2022 | 222,000.00 |
| Jun 30, 2022 | 72,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 24,000.00 |
| Dec 31, 2019 | 36,000.00 |
| Sep 30, 2019 | 50,000.00 |